[NPPA insights](https://indusdesk.com/nppa/insights/)

# NPPA fixes retail prices for 34 new drugs

https://indusdesk.com/nppa/insights/nppa-fixes-retail-prices-for-34-new-drugs/

The National Pharmaceutical Pricing Authority (NPPA) issued S.O. 5998(E) on November 2, 2026. NPPA order S.O. 5998(E) of November 2, 2026 fixes retail prices, excluding GST, for 34 new drug formulations under paragraphs 5, 11 and 15 of the DPCO, 2013.

NPPA · November 2, 2026

Vishnu Gupta

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals of the Ministry of Chemicals and Fertilizers, issued Order S.O. 5998(E) dated November 2, 2026, published the same day in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5766. It uses the powers in paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013 (DPCO, 2013), read with S.O. 1394(E) of May 30, 2013, S.O. 5249(E) of November 11, 2022 and S.O. 3516(E) of June 30, 2026.

The order fixes the retail price, exclusive of Goods and Services Tax (GST), of 34 formulations, each with its strength, unit and manufacturer and marketing company. They include oral suspensions, an oral solution, drops, tablets, capsules, injections, orally disintegrating strips, a gel and three combikits of vonoprazan with amoxicillin, two of them also with clarithromycin. Prices run from ₹0.60 per ml for an ibuprofen and paracetamol suspension to ₹5,623.07 per vial for Gemcitabine Injection 1.4g/36.84 ml. The table below lists all 34.

Each formulation is a "new drug" under paragraph 2(1)(u) of the DPCO, 2013, and the manufacturer named in the table must fix its retail price at no more than the price listed. Any other existing manufacturer launching the same new drug, with the same name, strength and unit, within twelve months of the order's publication in the Official Gazette may do so at no more than that price, if it files Form-IA on IPDMS 2.0 with supporting documents within one month of launch. GST may be added only if it has actually been paid or is payable. The manufacturer works out the price of a pack under paragraph 11 and must issue a price list in Form V to NPPA through IPDMS, with a copy to the State Drug Controller and dealers, and retailers and dealers must display it. A manufacturer or marketing company that does not keep to the price must deposit the overcharged amount with interest under the DPCO, 2013 read with the Essential Commodities Act, 1955.

The order does not give pack sizes, a maximum retail price for a pack or a date from which the prices apply, and it does not say when any of the drugs were launched. It is signed by Bhiva Ram Yadav, Assistant Director, under PN/285/153/2026/F/F. No. 8(153)/2026/D.P./NPPA-Div.-II.

**Issued by**: National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers

**Document**: Order S.O. 5998(E)

**Dated**: November 2, 2026

**Published**: Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), No. 5766, November 2, 2026

**Legal basis**: Paragraphs 5, 11 and 15 of the DPCO, 2013, read with S.O. 1394(E) of May 30, 2013, S.O. 5249(E) of November 11, 2022 and S.O. 3516(E) of June 30, 2026

**Formulations**: 34 new drugs under paragraph 2(1)(u) of the DPCO, 2013

**Prices**: Retail prices, excluding GST, from ₹0.60 per ml to ₹5,623.07 per vial

**Other makers**: May launch the same new drug within twelve months of publication at no more than the notified price, filing Form-IA on IPDMS 2.0 within one month of launch

**Price list**: Form V to NPPA through IPDMS, copy to the State Drug Controller and dealers

**Takes effect**: The order states no date; Form V is to be issued from the date of notification

**Signed by**: Bhiva Ram Yadav, Assistant Director

## The 34 retail prices

| Sl. No. | Formulation | Strength | Unit | Manufacturer & marketing company | Retail price, excluding GST (₹) |
|---|---|---|---|---|---|
| 1 | Alginate Raft-forming Oral Suspension B.P. | Each 5 ml contains: Sodium Alginate IP 250 mg, Sodium Bicarbonate IP 133.5 mg, Calcium Carbonate IP 80mg | 1 ML | M/s ESPI Industries & Chemicals Pvt Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 0.97 |
| 2 | Amoxycillin and Potassium Clavulanate for Oral Suspension | Each Combipack Contains: (A) 1 Bottle of Amoxycillin and Potassium Clavulanate for Oral Suspension IP; Each 5 ml of Constituted Suspension Contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400 mg, Potassium Clavulanate Diluted IP Eq. to Clavulanic Acid 57 mg; (B) 1 Vial of Sterile Water for Injections IP; Each Vial Contains: Sterile Water for Injections IP 30 ml | 1 ML | M/s Malik Lifesciences Pvt. Ltd./ M/s Apex Laboratories Pvt. Ltd. | 5.10 |
| 3 | Benfotiamine, Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Chromium Picolinate, Myo-Inositol, Pyridoxine Hydrochloride Tablets | Each Film Coated Tablet Contains: Benfotiamine 200 mg, Methylcobalamin IP 1500 mcg, Alpha Lipoic Acid IP 200 mg, Folic Acid IP 1.5 mg, Chromium Picolinate IP 200 mcg, Myo-Inositol IP 100 mg, Pyridoxine Hydrochloride IP 3 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd. | 24.01 |
| 4 | Ceftriaxone & Tazobactam Injection | Each Vial Contains: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone anhydrous 500 mg, Sterile Tazobactam Sodium IP eq. to Tazobactam 62.5 mg | 1 Vial | M/s Maya Biotech Pvt. Ltd./ M/s Vivaldis Health and Foods Pvt. Ltd. | 125.07 |
| 5 | Ciprofloxacin and Dexamethasone Eye Drops | Composition: Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 0.3% w/v, Dexamethasone IP 0.1% w/v, Benzalkonium Chloride Solution IP 0.02% v/v (As Preservative) | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Wellgen Medicare LLP | 2.71 |
| 6 | Doxylamine Succinate & Pyridoxine Hydrochloride Extended-Release Tablets | Each Film Coated Extended-Release Tablet Contains: Doxylamine Succinate USP 20 mg, Pyridoxine Hydrochloride IP 20 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Mankind Pharma Ltd. | 13.14 |
| 7 | Gemcitabine Injection 1.4g/36.84 ml | Each ml contains: Gemcitabine Hydrochloride IP Eq. to Gemcitabine 38 mg | 1 Vial | M/s Adley Formulations Pvt. Ltd. | 5623.07 |
| 8 | Gentamicin Sulphate, Dexamethasone Sodium Phosphate Eye/Ear Drops | Gentamicin Sulphate IP Eq. to Gentamicin base 0.3% w/v, Dexamethasone Sodium Phosphate IP Eq. to Dexamethasone Phosphate 0.1% w/v, Sodium Methylparaben IP 0.05% w/v (as Preservative), Sodium Propylparaben IP 0.01% w/v (as Preservative) | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Wellgen Medicare LLP | 1.75 |
| 9 | Ibuprofen & Paracetamol suspension | Each 5 ml contains: Ibuprofen IP 100 mg, Paracetamol IP 162.5 mg | 1 ML | M/s Innova Captab Ltd./ M/s Torrent Pharmaceuticals Ltd | 0.60 |
| 10 | Metformin Extended-Release and Sitagliptin Tablets | Each Film coated tablet contains: Metformin Hydrochloride IP 500mg (As Extended Release), Sitagliptin Phosphate Monohydrate IP Eqv. to Sitagliptin 100mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s FDC Ltd. | 13.92 |
| 11 | Methotrexate Oral Solution | Each ml contains: Methotrexate IP 2 mg | 1 ML | M/s Beta Drugs Ltd./ M/s Ipca Laboratories Ltd. | 12.70 |
| 12 | Methylprednisolone Tablets | Each uncoated tablet contains: Methylprednisolone IP 4 mg | 1 Tablet | M/s Foregen Healthcare Ltd./ M/s Zorvia Healthcare Ltd. | 5.30 |
| 13 | Methylprednisolone Tablets | Each uncoated tablet contains: Methylprednisolone IP 16 mg | 1 Tablet | M/s Foregen Healthcare Limited/ M/s Zorvia Healthcare Ltd. | 10.28 |
| 14 | Moxifloxacin Eye Drops IP | Composition: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v, Benzalkonium Chloride Solution IP 0.02% w/v (As Preservative) | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd/ M/s Wellgen Medicare LLP | 35.37 |
| 15 | Moxifloxacin Hydrochloride & Dexamethasone Phosphate Eye Drops | Each ml contains: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v, Dexamethasone Sodium Phosphate IP Eq. to Dexamethasone Phosphate 0.1% w/v, Benzalkonium Chloride Solution IP 0.01% v/v (As Preservative) | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd/ M/s Wellgen Medicare LLP | 20.40 |
| 16 | Multivitamin and Multi Mineral drops | Each ml Contains: Cholecalciferol (as stabilized) IP 200 IU, Pyridoxine HCL IP 0.5 mg, Niacinamide IP 5 mg, Cyanocobalamin IP 1 mcg, Sodium Selenite Pentahydrate BP eq. to elemental Selenium 10 mcg, Zinc Sulphate Monohydrate IP eq. to elemental Zinc 2 mg, Manganese Sulphate Monohydrate BP eq. to elemental Manganese 3 mcg, Sodium Molybdate dihydrate BP eq. to elemental Molybdenum 1 mcg, L-Lysine hydrochloride IP 30 mg, Potassium Iodide IP eq. to elemental Iodine 20 mcg, Biotin IP 5 mcg, Chromium Picolinate IP eq. to elemental Chromium 1 mcg, Myo-inositol IP 10 mg, Beta carotene Dispersion 2.5 % 18 mg | 1 ML | M/s Ordain Healthcare Global Pvt. Ltd/ M/s Mapra Laboratories Pvt. Ltd. | 3.20 |
| 17 | myo-Inositol and Metformin Hydrochloride (SR) Tablets | Each Film Coated Bilayered Tablet Contains: myo-Inositol IP 600 mg, Metformin Hydrochloride IP 500 mg (As sustained release) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Zorvia Healthcare Ltd. | 24.45 |
| 18 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg, Mefenamic Acid IP 100 mg | 1 ML | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s Profic Organic Ltd. | 0.95 |
| 19 | Paracetamol and Caffeine Tablets | Each uncoated tablet contains: Paracetamol IP 650 mg, Caffeine Anhydrous IP 50 mg | 1 Tablet | M/s Alkem Health Science (A Unit of Alkem Laboratories Ltd) Unit-2/ M/s Alkem Laboratories Ltd. | 3.84 |
| 20 | Rosuvastatin, Aspirin and Clopidogrel Capsules | Each Hard Gelatin Capsule Contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg (As film coated tablet), Aspirin IP 75 mg (As Gastro - resistant Tablet), Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film coated tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd/ M/s Sun Pharmaceutical Industries Ltd | 25.21 |
| 21 | Rosuvastatin, Aspirin and Clopidogrel Capsules | Each Hard Gelatin Capsule Contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg (As film coated tablet), Aspirin IP 75 mg (As Gastro - resistant Tablet), Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film coated tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd/ M/s Sun Pharmaceutical Industries Ltd | 16.56 |
| 22 | Tranexamic Acid and Mefenamic Acid Tablets | Each film coated tablet contains: Tranexamic Acid IP 500 mg, Mefenamic Acid IP 250 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ M/s Ajanta Pharma Ltd. | 35.81 |
| 23 | Vitamin D3 (Cholecalciferol) Drops | Each ml contains: Vitamin D3 IP 800 IU (Cholecalciferol) | 1 ML | M/s Synokem Lifesciences Pvt. Ltd./ M/s FDC Ltd. | 6.36 |
| 24 | Paracetamol Injection 1000 MG/4 ML | Each ml contains: Paracetamol IP 250 mg | 1 Vial | M/s Troikaa Pharmaceuticals Ltd. | 341.26 |
| 25 | Ondansetron Orally Disintegrating Strips | Each orally disintegrating strip contains: Ondansetron IP 2 mg | 1 Strip | M/s Zim Laboratories Ltd / M/s Sun Pharma Laboratories Ltd | 15.90 |
| 26 | Ondansetron Orally Disintegrating Strips | Each orally disintegrating strip contains: Ondansetron IP 4 mg | 1 Strip | M/s Zim Laboratories Ltd / M/s Sun Pharma Laboratories Ltd | 17.25 |
| 27 | Diclofenac Diethylamine, Methyl Salicylate and Menthol Gel | Composition: Diclofenac Diethylamine IP 2.32 % w/w Eq. To Diclofenac Sodium 2% w/w, Methyl Salicylate IP 10% w/w, Menthol IP 5% w/w | 1 Gram | M/s Marine Life Sciences/ M/s Aristo Laboratories Pvt. Ltd. | 4.09 |
| 28 | Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains: Diclofenac sodium IP 50 mg, Paracetamol IP 325 mg | 1 Tablet | M/s Shiva Biogenetic Pharmaceuticals Pvt Ltd./ M/s Aristo Laboratories Pvt. Ltd. | 5.92 |
| 29 | Combikit of Clarithromycin, Vonoprazan and Amoxicillin Tablets | Each strip contains: (A) Clarithromycin Tablets IP (2 Tablets), each Film Coated Tablet Contains: Clarithromycin IP 500 mg; (B) Vonoprazan Tablets (2 Tablets), each Film Coated Tablet Contains: Vonoprazan Fumarate Eq.to Vonoprazan 20 mg; (C) Amoxicillin Tablets USP (2 Tablets), each Film Coated Tablet Contains: Amoxycyllin Trihydrate IP Eq. to Amoxycillin 1000 mg | 1 Strip | M/s Malik Lifesciences Pvt. Ltd./ M/s Mankind Pharma Limited | 118.52 |
| 30 | Combikit of Vonoprazan and Amoxicillin Tablets | Each strip contains: (A) Vonoprazan Tablets (2 Tablets), each Film Coated Tablet Contains: Vonoprazan Fumarate Eq. to Vonoprazan 20 mg; (B) Amoxicillin Tablets USP (3 Tablets), each Film Coated Tablet Contains: Amoxycyllin Trihydrate IP Eq. to Amoxycillin 1000 mg | 1 Strip | M/s Malik Lifesciences Pvt. Ltd./ M/s Dr. Reddy's Laboratories Limited | 50.53 |
| 31 | Combikit of Vonoprazan tablet, Clarithromycin tablet and Amoxicillin Capsules | Each combipack contains: A. Vonoprazan Tablets (2 Tablets), each film coated tablet contains: Vonoprazan Fumarate eq. to Vonoprazan 20mg; B. Clarithromycin tablets (2 Tablets), each film coated tablet contains: Clarithromycin IP 500mg; C. Amoxycillin Capsules (4 Capsules), each hard gelatin capsule contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 500mg | 1 Combipack | M/s Theon Pharmaceuticals Limited/ M/s Zydus Healthcare Limited | 122.34 |
| 32 | Bisoprolol Fumarate, Telmisartan and Cilnidipine Tablets | Each film coated bilayered tablet contains: Bisoprolol Fumarate IP 2.5 mg, Telmisartan IP 40 mg, Cilnidipine IP 10 mg | 1 Tablet | M/s Windlas Biotech Limited/ M/s Eris Lifesciences Limited | 19.11 |
| 33 | Bisoprolol Fumarate, Telmisartan and Cilnidipine Tablets | Each film coated bilayered tablet contains: Bisoprolol Fumarate IP 5 mg, Telmisartan IP 40 mg, Cilnidipine IP 10 mg | 1 Tablet | M/s Windlas Biotech Limited/ M/s Eris Lifesciences Limited | 20.87 |
| 34 | Carbimazole Tablets | Each uncoated tablet contains: Carbimazole IP 2.5 mg | 1 Tablet | M/s Abbott Healthcare Pvt. Ltd. | 1.34 |

[The order](https://files.indusdesk.com/nppa/orders/2026/so-5998e.pdf) (PDF, 800 KB)

Source: [Gazette of India, CG-DL-E-03112026-277614](https://egazette.gov.in/WriteReadData/2026/277614.pdf).

Checked against the official copy on November 7, 2026.

- [All NPPA insights](https://indusdesk.com/nppa/insights/)
